AKT1 and hepatocellular carcinoma: Experimental approaches such as dual-luciferase assays, RNA pull-down, and loss/gain-of-function studies are needed to confirm molecular interactions and clarify downstream effects on key signaling pathways like PI3K/Akt in HCC progression.